Skip to main navigation

Main Menu
About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers
Amgen Worldwide

Overview
Research and Development Strategy
Overview <i class="fa fa-external-link"></i>
Scientific Advisory Boards
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Clinical Trials
Scientific Community Initiatives   
Manufacturing

Overview
About Clinical Trails
Amgen Clinical Trails<i class="fa fa-external-link"></i>
Clinical Study Report Synopses<i class="fa fa-external-link"></i>
Clinical Trial Diversity
Lay Summary of Clinical Trail Result<i class="fa fa-external-link"></i>
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies<i class="fa fa-external-link"></i>

All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags

COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities

About
Science
PRODUCTS
Responsibility
Stories
Newsroom
Partners
Investors
Careers

Breadcrumb

Home
Investors
Presentations

Presentations

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

Presentations

04.27.2022

Q1 2022 Earnings Presentation 2.3 MB

03.29.2022

Chairman and CEO Letter and Amgen Inc. 2021 Annual Report 3.7 MB

02.08.2022

AMGEN BUSINESS REVIEW MEETING PRESENTATION 143.3 MB

01.11.2022

Amgen at 40th Annual JP Morgan Healthcare Conference Presentation 623.4 KB

11.02.2021

Q3 2021 Earnings Presentation 1.8 MB

10.04.2021

Amgen Presentation on Inflammation Portfolio from EADV 1.9 MB

09.21.2021

Amgen Investor Presentation September 2021 1.3 MB

09.16.2021

Amgen Conference Call from ESMO Presentation 1.1 MB

08.03.2021

Q2 2021 Earnings Presentation 1.7 MB

06.04.2021

ASCO 2021 Highlights Presentation 2.2 MB

04.27.2021

Q1 2021 Earnings Presentation 1.7 MB

03.30.2021

Chairman and CEO Letter and Amgen Inc. 2020 Annual Report 3.6 MB

02.26.2021

Amgen Investor Conference Call from AAAAI 830.7 KB

02.02.2021

Q4 2020 Earnings Presentation 1.7 MB

01.21.2021

Analyst WCLC Presentation 1.4 MB

Navbar w/ text

Investors
News & Events
Financials
Pipeline
Stock
ESG
Resources

Earnings

Show all

Q1 2022

Q1 2022 Amgen Earnings Conference Call
AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
Q1 2022 Earnings Presentation 2.3 MB

Data as of:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stay Connected With Amgen.

Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2020 Amgen Inc. All Rights Reserved.